Glenmark Pharma inks exclusive licensing agreement with Lotus InternationalGlenmark will receive an upfront payment as well as regulatory and sales-based milestone payments from Lotus, it added.
Glenmark gets USFDA nod for nasal spray to treat seasonal allergic rhinitisGlenmark Pharmaceuticals on Friday said its subsidiary has received approval from the US health regulator to market Ryaltris, a nasal spray...
Glenmark gets marketing approval for Ryaltris in 13 EU, UK countriesSales of the nasal spray continue to progress well in Australia, South Africa, Ukraine and Uzbekistan, it said adding the company has also ...
Glenmark Pharma to launch its nasal spray Ryaltris in EUThe drug relieves symptoms of allergic rhinitis, including stuffy nose, runny nose, nasal itching, sneezing, as well as itchy, red and wate...
Glenmark inks pact with Menarini Group to commercialise nasal spray in EuropeGlenmark Specialty, a Switzerland-based unit of the company, has entered into an exclusive licensing agreement with the Menarini Group for ...
FIPB clears 6 FDI proposals worth Rs 1,187 croreWith growth in FDI in important sectors like services and manufacturing, overall foreign inflows in the country rose by 30 per cent to $21....
FIPB clears 6 FDI proposals worth Rs 1,200 croreSome of the proposals which were deferred were those of Crest Premedia Solutions Pvt Ltd, You Broadband India and Scientific Publishing Ser...
Govt approves 12 FDI proposals worth over Rs 2,609 crThe government today said it has approved 12 FDI proposals, including that of pharma firm Claris Otsuka, totalling over Rs 2,609 crore.
- Invida Holdings Pvt Ltd acquires Shalaks' dermatology, primary care portfolio
Invida Holdings Pvt Ltd today said it has acquired the dermatology and primary care portfolio of Shalaks Pharmaceuticals Pvt Ltd.